Liu W - Search Results

1

Case Report: Multi-Omics Analysis and CAR-T Treatment of a Chronic Myeloid Leukemia Blast Crisis Case 5 Years After the Discontinuation of TKI.

Miao YR, Liu W, Zhong Z, You Y, Tang Y, Li W, Zhu X, Guo AY. Miao YR, et al. Among authors: liu w. Front Oncol. 2021 Sep 21;11:739871. doi: 10.3389/fonc.2021.739871. eCollection 2021. Front Oncol. 2021. PMID: 34621680 Free PMC article.

2

The interaction of tumor cells and myeloid-derived suppressor cells in chronic myelogenous leukemia.

Xu H, Liu J, Shen N, Zhao Z, Cui J, Zhou S, Jiang L, Zhu X, Tang L, Liang H, Liu W, Zhu Z, Meng L, Zhu X. Xu H, et al. Among authors: liu j, liu w. Leuk Lymphoma. 2020 Jan;61(1):128-137. doi: 10.1080/10428194.2019.1658098. Epub 2019 Sep 18. Leuk Lymphoma. 2020. PMID: 31530212

3

The Impact of Tyrosine Kinase Inhibitors on Chronic Myeloid Leukemia Stem Cells and the Implication in Discontinuation.

Jiang L, Wang H, Zhu X, Liu W, Zhou S, Geng Z, Xiao Y, Zou P, You Y, Li Q, Zhu X. Jiang L, et al. Among authors: liu w. Stem Cells Dev. 2019 Nov 15;28(22):1480-1485. doi: 10.1089/scd.2019.0117. Epub 2019 Oct 22. Stem Cells Dev. 2019. PMID: 31530245

4

Comparison of chronic myeloid leukemia stem cells and hematopoietic stem cells by global proteomic analysis.

Zhou S, Zhu X, Liu W, Cheng F, Zou P, You Y, Xiao Y, Guo A, Zhu X. Zhou S, et al. Among authors: liu w. Biochem Biophys Res Commun. 2020 Feb 5;522(2):362-367. doi: 10.1016/j.bbrc.2019.11.092. Epub 2019 Nov 22. Biochem Biophys Res Commun. 2020. PMID: 31767149

5

Ruxolitinib add-on in corticosteroid-refractory graft-vs-host disease after allogeneic stem cell transplantation: Results from a retrospective study on 38 Chinese patients.

Dang SH, Liu Q, Xie R, Shen N, Zhou S, Shi W, Liu W, Zou P, You Y, Zhong ZD. Dang SH, et al. Among authors: liu q, liu w. World J Clin Cases. 2020 Mar 26;8(6):1065-1073. doi: 10.12998/wjcc.v8.i6.1065. World J Clin Cases. 2020. PMID: 32258077 Free PMC article.

6

AICAR and Decitabine Enhance the Sensitivity of K562 Cells to Imatinib by Promoting Mitochondrial Activity.

Zhu XY, Liu W, Liang HT, Tang L, Zou P, You Y, Zhu XJ. Zhu XY, et al. Among authors: liu w. Curr Med Sci. 2020 Oct;40(5):871-878. doi: 10.1007/s11596-020-2266-1. Epub 2020 Oct 29. Curr Med Sci. 2020. PMID: 33123902

7

A folate receptor 3 SNP promotes mitochondria-induced clonogenicity of CML leukemia cells: Implications for treatment free remission.

Shen N, Liu T, Liu W, Zhong Z, Li Q, Zhu X, Zou P, You Y, Guo AY, Zhu X. Shen N, et al. Among authors: liu w, liu t. Clin Transl Med. 2021 Feb;11(2):e317. doi: 10.1002/ctm2.317. Clin Transl Med. 2021. PMID: 33634983 Free PMC article. No abstract available.

8

Molecular Biomarker of Drug Resistance Developed From Patient-Derived Organoids Predicts Survival of Colorectal Cancer Patients.

Chen L, Tian B, Liu W, Liang H, You Y, Liu W. Chen L, et al. Among authors: liu w. Front Oncol. 2022 Mar 29;12:855674. doi: 10.3389/fonc.2022.855674. eCollection 2022. Front Oncol. 2022. PMID: 35425715 Free PMC article.

9

ACSL1 promotes imatinib-induced chronic myeloid leukemia cell senescence by regulating SIRT1/p53/p21 pathway.

Liu W, Zhu X, Tang L, Shen N, Cheng F, Zou P, You Y, Yuan G, Li Q, Zhu X. Liu W, et al. Sci Rep. 2022 Oct 26;12(1):17990. doi: 10.1038/s41598-022-21009-6. Sci Rep. 2022. PMID: 36289272 Free PMC article.

10

Strategies for Reducing Toxicity and Enhancing Efficacy of Chimeric Antigen Receptor T Cell Therapy in Hematological Malignancies.

Wang H, Tang L, Kong Y, Liu W, Zhu X, You Y. Wang H, et al. Among authors: liu w. Int J Mol Sci. 2023 May 23;24(11):9115. doi: 10.3390/ijms24119115. Int J Mol Sci. 2023. PMID: 37298069 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59,511 results

Search Page

Filters